Beiträge
Brain Tumor Immunotherapy: What have We Learned so Far?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-06-17 / Front Oncol 2015;5:98Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-32Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
/in Glioblastoma, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-01-15 / J Cancer 2015;6(3):203-17Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
/in Glioblastoma, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2014-09-19 / Int. J. Cancer 2015 Mar;136(5):E313-25Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2014-05-13 / Cytotherapy 2014 Jul;16(7):946-64Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer, Uterine Cancer /von 2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-11Dendritic cell immunotherapy in uterine cancer
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Uterine Cancer /von 2014-01-01 / Hum Vaccin Immunother 2014;10(7):1822-7Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Uterine Cancer /von 2013-12-01 / Anticancer Res. 2013 Dec;33(12):5495-500Myeloid-derived suppressor cells in glioma
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-11-12 / Expert Rev Neurother 2013 Dec;13(12):1395-406
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
- Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
- A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma